Cosmetic Dermatology

Glenmark, Cosmo get MHRA nod to market acne treatment medication in UK

Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals NV have received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a product for the treatment of acne vulgaris in the United Kingdom. In a joint statement, the companies said they have received approval for Winlevi, a topical treatment for acne vulgaris in patients aged 12 years and older. As part of the agreement inked in September 2023, Glenmark in-licensed the product from Cosmo Pharmaceuticals for distribution in Europe and South Africa. "Our partnership with Cosmo Pharmaceuticals plays an important role in enabling us to expand our dermatology portfolio, and we are proud to offer this new treatment to market that can improve the quality of life for those living with acne," Glenmark Pharmaceuticals President & Business Head - Europe and Emerging Markets Christoph Stoller said. Cosmo CEO Giovanni Di Napoli said the milestone underscores the company's commitment, alongside ...

FDA proposes new testing guidelines to ensure asbestos-free cosmetics

Cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos under a new proposed federal rule. The proposal from the Food and Drug Administration on Thursday and mandated by Congress is intended to reassure consumers about the safety of makeup, baby powder and other personal care products. It follows years of lawsuits against Johnson & Johnson and other companies alleging links between talc-based baby powder and cancer. Despite the lawsuits, research has found mixed evidence of a potential link between cancer and talc, although the possibility has been recognised for decades because of how it is mined. Talc is a mineral used to absorb moisture or improve the texture, feel and colour of cosmetics. It is mined from underground deposits that are sometimes located near the toxic mineral asbestos. The risk of cross contamination has long been recognised by cosmetic companies. But recent FDA-sponsored testing hasn't uncovered any ..

Mamaearth parent acquires cosmetic formulation brand CosmoGenesis

Founded by Rohini Manoj in 2011, CosmoGenesis has until now facilitated over 5,000 cosmetic and personal care formulations for businesses in India using its fully-equipped, state-of-the-art laboratory

Honasa's Derma Co crosses annual run rate of Rs 350 cr in June quarter

The company has also acquired stakes in BBlunt and Dr. Sheth's

Expensive deal valuations to hit Torrent Pharma's near-term earnings

Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers

Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August

Rise of cosmetic dermatology space gets big pharma looking for buyouts

According to reports, Torrent Pharmaceuticals is set to sign a deal to acquire Curatio Healthcare, a maker of skincare products, for Rs 2100 crore.

Cosmetics firm L'Oreal ties up with Nasscom to innovate business operations

Joint initiative to explore potential application of AI, ML IoT and AR/VR in cosmetics and dermatology, and product development and personalisation at L'Oreal

Cosmetic Dermatology: Common procedures, challenges, advancements, and more

Pigmentation treatment has typically been done through use of Hydroquinone creams prescribed by doctors, or retinol along with anti-inflammatory creams